Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Yuan Li Shen"'
Autor:
Kathleen Maignan, Lola A. Fashoyin-Aje, Aracelis Z. Torres, Laura L. Fernandes, Thomas Gwise, Shrujal B. Baxi, James P. Roose, Donna R. Rivera, Yuan Li Shen, Paul G. Kluetz, Nicole J. Gormley
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 4, Pp 1-6 (2022)
Abstract This retrospective observational study evaluated racial disparities among Black and White patients with multiple myeloma (MM). We included patients from a longitudinal de-identified EHR-derived database who had ≥2 visits recorded on or aft
Externí odkaz:
https://doaj.org/article/4676e1178d1f40689b1186a68dd087aa
Autor:
Olga Marchenko, Rajeshwari Sridhara, Qi Jiang, Elizabeth Barksdale, Yuki Ando, Dinesh De Alwis, Katie Brown, Laura Fernandes, Mark T. J. van Bussel, Qiuyi Choo, Michael Coory, Elizabeth Garrett-Mayer, Thomas Gwise, Lorenzo Hess, Rong Liu, Sumithra Mandrekar, Daniele Ouellet, José Pinheiro, Martin Posch, Nam Atiqur Rahman, Khadija Rerhou Rantell, Andrew Raven, Sarem Sarem, Suman Sen, Mirat Shah, Yuan Li Shen, Richard Simon, Marc Theoret, Ying Yuan, Richard Pazdur
Publikováno v:
Statistics in Biopharmaceutical Research. :1-7
Autor:
Yuan-Li Shen, Sirisha Mushti, Flora Mulkey, Thomas Gwise, Xin Wang, Jiaxi Zhou, Xin Gao, Shenghui Tang, Marc R. Theoret, Richard Pazdur, Rajeshwari Sridhara
Publikováno v:
Statistics in Biopharmaceutical Research. 15:315-317
Autor:
Rajeshwari Sridhara, Olga Marchenko, Qi Jiang, Elizabeth Barksdale, Jie Chen, Nancy Dreyer, Lola Fashoyin-Aje, Elizabeth Garrett-Mayer, Nicole Gormley, Thomas Gwise, Lorenzo Hess, Sumithra Mandrekar, Francesco Pignatti, Khadija Rantell, Andrew Raven, Yuan-Li Shen, Harpreet Singh, Craig L. Tendler, Marc Theoret, Richard Pazdur
Publikováno v:
Statistics in Biopharmaceutical Research. 15:450-456
Autor:
Rajeshwari Sridhara, Elizabeth Barksdale, Olga Marchenko, Qi Jiang, Yuki Ando, Erick Bloomquist, Michael Coory, Melissa Crouse, Evgeny Degtyarev, Theodor Framke, Boris Freidlin, David E. Gerber, Thomas Gwise, Filip Josephson, Lorenzo Hess, Paul Kluetz, Daniel Li, Sumithra Mandrekar, Martin Posch, Khadija Rantell, Bohdana Ratitch, Andrew Raven, Kit Roes, Kaspar Rufibach, Sinan B. Sarac, Richard Simon, Harpreet Singh, Marc Theoret, Andrew Thomson, Emmanuel Zuber, Yuan Li Shen, Richard Pazdur
Publikováno v:
Statistics in Biopharmaceutical Research. 15:444-449
Autor:
Richard Pazdur, Ann T. Farrell, Reena Philip, Albert Deisseroth, Rajeshwari Sridhara, Donna Roscoe, Yuan Li Shen, Donna Przepiorka, Aaron Schetter, Qing Xu, Emily Y. Jen
Grouped terms used in safety analyses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bb3c71a1ae3311a34043cbf269cfa88
https://doi.org/10.1158/1078-0432.22474197.v1
https://doi.org/10.1158/1078-0432.22474197.v1
Autor:
Richard Pazdur, Ann T. Farrell, Kirsten B. Goldberg, Ruby Leong, Chao Liu, Christopher M. Sheth, Yuan-Li Shen, Donna Przepiorka, Pedro L. Del Valle, Luning Zhuang, Sriram Subramaniam, Kunthel By, Kelly J. Norsworthy
Supplementary Figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f695b031ea2746b3b535c50a6f75f0
https://doi.org/10.1158/1078-0432.22472658.v1
https://doi.org/10.1158/1078-0432.22472658.v1
Autor:
Richard Pazdur, Ann T. Farrell, Kirsten B. Goldberg, Gene M. Williams, Rosane Charlab, Christopher M. Sheth, Yuan-Li Shen, Albert Deisseroth, Donna Przepiorka, Sarah E. Dorff, Ramadevi Gudi, Vicky Hsu, Lola Luo, Kelly J. Norsworthy
Rate of CR+CRh by subgroup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be902c39ee395a68d595086357bb634
https://doi.org/10.1158/1078-0432.22469381.v1
https://doi.org/10.1158/1078-0432.22469381.v1
Autor:
Richard Pazdur, Ann T. Farrell, Kirsten B. Goldberg, Ruby Leong, Chao Liu, Christopher M. Sheth, Yuan-Li Shen, Donna Przepiorka, Pedro L. Del Valle, Luning Zhuang, Sriram Subramaniam, Kunthel By, Kelly J. Norsworthy
Supplementary Table S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::662c2fafd3def9de60e42b7af6e56a78
https://doi.org/10.1158/1078-0432.22472652.v1
https://doi.org/10.1158/1078-0432.22472652.v1
Autor:
Richard Pazdur, Ann T. Farrell, Reena Philip, Albert Deisseroth, Rajeshwari Sridhara, Donna Roscoe, Yuan Li Shen, Donna Przepiorka, Aaron Schetter, Qing Xu, Emily Y. Jen
On March 29, 2018, the FDA granted accelerated approval for blinatumomab (Blincyto; Amgen, Inc.) for the treatment of adults and children with B-cell precursor acute lymphoblastic leukemia (BCP ALL) in first or second complete remission with minimal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4633f148f2828c48b9597e5e86f99f2c
https://doi.org/10.1158/1078-0432.c.6528714
https://doi.org/10.1158/1078-0432.c.6528714